In a recent multicenter prospective study conducted at three hospitals in Tennessee and Georgia, including Vanderbilt University Medical Center, researchers at VUMC found a substantial burden of hospitalizations for community-acquired ...
Aug 6, 2025
0
28
The U.S. Food and Drug Administration has approved Merck's Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.
Jun 24, 2024
0
41
The global impact of the coronavirus pandemic has ignited a renewed focus on emerging and re-emerging infectious diseases. Researchers at Osaka Metropolitan University are making great strides in combating pneumococcal pneumonia, ...
Nov 28, 2023
0
51
Vaccine-resistant pneumonia has increased since a vaccine targeting 13 serotypes of the Streptococcus pneumoniae bacteria was introduced into the Australian routine childhood immunization program.
Dec 1, 2022
0
42
